Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  entinostat
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Exemestane with or without Entinostat in Treating Postmenopausal Patients with Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: E2112, NCI-2014-00746, ECOG-E2112, NCT02115282
Entinostat in Combination with Aldesleukin in Treating Patients with Metastatic Kidney Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 145208, NCI-2012-02900, CDR0000662915, NCI 7870, NCT01043159, RPCI #23, 7870, NCT01038778
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC and Melanoma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: SNDX-275-0601, NCI-2015-01180, NCT02437136
Azacitidine and Entinostat Followed by Nivolumab or Nivolumab Alone in Treating Patients with Recurrent Metastatic Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Age: Over 18
Trial IDs: J1353, NCI-2013-02334, J1353/ NA_00084192, NA_00084192, NA_00084192/CIR00003289, NCT01928576
Azacitidine and Entinostat before Chemotherapy in Treating Patients with Advanced Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NA_00081948/J1309, NCI-2013-00949, NA_00081948, NCT01846897, 9253, NCT01935947
Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients with Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated with Trastuzumab Only
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2010-0842, NCI-2011-03222, CDR0000710891, 8871, MDA-2010-0842, NCT01434303
Entinostat, Nivolumab, and Ipilimumab in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKCCC J15, NCI-2015-00741, L9844, 9844, NCT02453620
Start Over